Cinven sells stake in SYNLAB to US-based Labcorp

By
Maria Davies
-
Mathieu Floreani, CEO SYNLAB Group

Private equity firm Cinven has announced plans to sell a 15% indirect minority stake in European diagnostics leader SYNLAB to US-based laboratory services company Labcorp. The €140m deal will see Labcorp, a global specialist in comprehensive laboratory services, join Cinven and other co-investors on SYNLAB’s holding company board, positioning itself to explore future collaboration opportunities…

Membership Required

You must be a HM Subscriber to view this content.

Subscribe Now »

Already have an account?